What is MOTS-c?
A mitochondrial-derived peptide studied for metabolic effects.
MOTS-c is a peptide encoded in mitochondrial DNA, studied for its effects on metabolism, exercise capacity, and longevity. Research is early-stage. It represents an emerging area of mitochondrial peptide research.
What the evidence says
The overall evidence grade for MOTS-c is C (limited — early or preliminary data, mostly mechanistic or animal). Emerging research area. Limited human clinical data.
Specific findings with supporting evidence:
- Affects metabolic pathways in research. Evidence grade C.
- May improve exercise capacity. Evidence grade C.
Best-supported outcomes:
- Research interest only.
Where marketing outpaces evidence:
- The claim that "Proven longevity benefits in humans" is not supported by the evidence (grade C).
- Marketing often overstates: Anti-aging miracle.
- Marketing often overstates: Metabolism booster.
- Marketing often overstates: Exercise in a pill.
Dose and timing
Take it in the morning. Research compound only.
Who it's for, and who should skip it
Most relevant for:
- Research interest only.
Not appropriate for:
- Anyone seeking proven therapy.
Safety and cautions
Important: Early research. Human clinical data is very limited. Important: Not FDA approved. Experimental research compound.
Common mistakes
- Expecting dramatic metabolic effects.
- Confusing preclinical with proven.
Myths vs reality
A common misconception: MOTS-c is a proven longevity peptide. In reality, research is early-stage with limited human data.
How it interacts with other compounds
- MOTS-c works well alongside humanin — both mitochondrial-derived peptides.
Questions people ask
What makes MOTS-c unique? It is encoded in mitochondrial DNA, representing a new peptide class.
Editorial note
This guide summarizes the published evidence on MOTS-c. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.